Research/art/teacher profile of a person
Name and surname:
MUDr. Juraj Javor, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Javor
I.2 - Name
Juraj
I.3 - Degrees
MD., PhD.
I.4 - Year of birth
1980
I.5 - Name of the workplace
Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava
I.6 - Address of the workplace
Dean´s Office, Špitálska ulica 24, 813 72 Bratislava
I.7 - Position
university teacher - assistant professor
I.8 - E-mail address
juraj.javor@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
www.portalvs.sk/regzam/detail/3494
I.10 - Name of the study field in which a person works at the university
Immunology
I.11 - ORCID iD
0000-0002-7741-5779

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2004
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2008
II.c - Study field and programme
15-15-9 Immunology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
university teacher - assistant professor Comenius University in Bratislava, Faculty of Medicine 2007 - present

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Immunology (in Slovak and English language) General Medicine I.+II. degree General Medicine
Immunology (in Slovak and English language) Dentistry I.+II. degree Dentistry
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
3
V.4.c - Dissertation (third degree)
0
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
30
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Clinical Immunology (in Slovak and English language) General Medicine I.+II. degree General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
136
VI.1.b - Over the last six years
37
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
41 outputs Web of Science / 35 outputs SCOPUS
VI.1.b - Over the last six years
19 outputs Web of Science / 14 outputs SCOPUS
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
385
VI.1.b - Over the last six years
207
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
290 citations Web of Science / 343 citations SCOPUS
VI.1.b - Over the last six years
165 citations Web of Science / 187 citations SCOPUS
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Javor J, Ďurmanová V, Klučková K, Párnická Z, Radošinská D, Šutovský S, Vašečková B, Režnáková V, Králová M, Gmitterová K, Zorad Š, Shawkatová I. Adiponectin Gene Polymorphisms: A Case-Control Study on Their Role in Late-Onset Alzheimer's Disease Risk. Life (Basel) 2024; 14(3): 346. doi: 10.3390/life14030346. (IF = 3,2; Q1)

2

Javor J, Bucová M, Ďurmanová V, Radošinská D, Párnická Z, Čierny D, Kurča E, Čopíková-Cudráková D, Gmitterová K, Shawkatová I. Alzheimer's Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis. Life (Basel) 2022; 12(7): 1094. doi: 10.3390/life12071094. (IF = 3,2; Q2)

3

Čierny D, Michalik J, Dubovan P, Škereňová M, Javor J, Kurča E, Dobrota D, Lehotský J. The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks. Journal of Neuroimmunology 2019; 330: 123-129. doi: 10.1016/j.jneuroim.2019.03.006. (IF = 3,125; Q2)

4

Durmanova V, Parnicka Z, Javor J, Minarik G, Vrazda L, Vaseckova B, Gmitterova K, Kralova M, Pecenak J, Filipcik P, Shawkatova I. A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease. Mediators of Inflammation 2018; 2018: 7623823. doi: 10.1155/2018/7623823. (IF = 3,545; Q2)

5

Javor J, Chmurova N, Parnicka Z, Ferencik S, Grosse-Wilde H, Buc M, Svecova D. TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population. Journal of the European Academy of Dermatology and Venereology 2010; 24(1): 65-68. doi: 10.1111/j.1468-3083.2009.03260.x. (IF = 3,309; Q1)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Javor J, Ďurmanová V, Klučková K, Párnická Z, Radošinská D, Šutovský S, Vašečková B, Režnáková V, Králová M, Gmitterová K, Zorad Š, Shawkatová I. Adiponectin Gene Polymorphisms: A Case-Control Study on Their Role in Late-Onset Alzheimer's Disease Risk. Life (Basel) 2024; 14(3): 346. doi: 10.3390/life14030346. (IF = 3,2; Q1)

2

Javor J, Bucová M, Ďurmanová V, Radošinská D, Párnická Z, Čierny D, Kurča E, Čopíková-Cudráková D, Gmitterová K, Shawkatová I. Alzheimer's Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis. Life (Basel) 2022; 12(7): 1094. doi: 10.3390/life12071094. (IF = 3,2; Q2)

3

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation 2021; 2021: 5573642. doi: 10.1155/2021/5573642. (IF = 4,529; Q3)

4

Čierny D, Michalik J, Dubovan P, Škereňová M, Javor J, Kurča E, Dobrota D, Lehotský J. The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks. Journal of Neuroimmunology 2019; 330: 123-129. doi: 10.1016/j.jneuroim.2019.03.006. (IF = 3,125; Q2)

5

Durmanova V, Parnicka Z, Javor J, Minarik G, Vrazda L, Vaseckova B, Gmitterova K, Kralova M, Pecenak J, Filipcik P, Shawkatova I. A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease. Mediators of Inflammation 2018; 2018: 7623823. doi: 10.1155/2018/7623823. (IF = 3,545; Q2)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Javor J, Králinský K, Sádová E, Červeňová O, Bucová M, Olejárová M, Buc M, Liptáková A. Association of interleukin-10 gene promoter polymorphisms with susceptibility to acute pyelonephritis in children. Folia Microbiologica (Praha) 2014; 59(4): 307-313. doi: 10.1007/s12223-014-0303-9.

Cited in: Yu J, Varella Pereira GM, Allen-Brady K, Cuffolo R, Siddharth A, Koch M, Chua JWF, Sorrentino F, Dytko O, Ng KY, Violette P, Khullar V, Wang ZT, Cartwright R. Genetic polymorphisms associated with urinary tract infection in children and adults: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 2023. doi: 10.1016/j.ajog.2023.12.018. Online ahead of print.

Cited in: Butler D, Ambite I, Wan MLY, Tran TH, Wullt B, Svanborg C. Immunomodulation therapy offers new molecular strategies to treat UTI. Nature Reviews Urology 2022; 19(7): 419-437. doi: 10.1038/s41585-022-00602-4.

Cited in: Ambite I, Butler D, Wan MLY, Rosenblad T, Tran TH, Chao SM, Svanborg C. Molecular determinants of disease severity in urinary tract infection. Nature Reviews Urology 2021; 18(8): 468-486. doi: 10.1038/s41585-021-00477-x.

2

Shawkatová I, Javor J, Párnická Z, Kozub P, Zilínková M, Frey P, Ferenčík S, Buc M. HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population. Folia Microbiologica (Praha) 2013; 58(4): 319-324. doi: 10.1007/s12223-012-0213-7.

Cited in: Huang YW, Tsai TF. HLA-Cw1 and Psoriasis. American Journal of Clinical Dermatology 2021; 22(3): 339-347. doi: 10.1007/s40257-020-00585-1.

Cited in: Chen L, Tsai TF. HLA-Cw6 and psoriasis. The British Journal of Dermatology 2018; 178(4): 854-862. doi: 10.1111/bjd.16083.

3

Javor J, Bucova M, Cervenova O, Kralinsky K, Sadova E, Suchankova M, Liptakova A. Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children. International Journal of Immunogenetics 2012; 39(4): 338-345. doi: 10.1111/j.1744-313X.2012.01096.x.

Cited in: Yu J, Varella Pereira GM, Allen-Brady K, Cuffolo R, Siddharth A, Koch M, Chua JWF, Sorrentino F, Dytko O, Ng KY, Violette P, Khullar V, Wang ZT, Cartwright R. Genetic polymorphisms associated with urinary tract infection in children and adults: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 2023. doi: 10.1016/j.ajog.2023.12.018. Online ahead of print.

Cited in: Schwartz L, de Dios Ruiz-Rosado J, Stonebrook E, Becknell B, Spencer JD. Uropathogen and host responses in pyelonephritis. Nature Reviews Nephrology 2023; 19(10): 658-671. doi: 10.1038/s41581-023-00737-6.

Cited in: Butler D, Ambite I, Wan MLY, Tran TH, Wullt B, Svanborg C. Immunomodulation therapy offers new molecular strategies to treat UTI. Nature Reviews Urology 2022; 19(7):419-437. doi: 10.1038/s41585-022-00602-4.

Cited in: Ambite I, Butler D, Wan MLY, Rosenblad T, Tran TH, Chao SM, Svanborg C. Molecular determinants of disease severity in urinary tract infection. Nature Reviews Urology 2021; 18(8): 468-486. doi: 10.1038/s41585-021-00477-x.

Cited in: Swamydas M, Gao JL, Break TJ, Johnson MD, Jaeger M, Rodriguez CA, Lim JK, Green NM, Collar AL, Fischer BG, Lee CC, Perfect JR, Alexander BD, Kullberg BJ, Netea MG, Murphy PM, Lionakis MS. CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival. Science Translational Medicine 2016; 8(322): 322ra10. doi: 10.1126/scitranslmed.aac7718.

4

Bucova M, Suchankova M, Dzurilla M, Vrlik M, Novosadova H, Tedlova E, Urban S, Hornakova E, Seligova M, Durmanova V, Penz P, Javor J, Paulovicova E. Inflammatory Marker sTREM-1 Reflects the Clinical Stage and Respiratory Tract Obstruction in Allergic Asthma Bronchiale Patients and Correlates with Number of Neutrophils. Mediators of Inflammation 2012; 2012: 628754. doi: 10.1155/2012/628754.

Cited in: Croteau-Chonka DC, Qiu W, Martinez FD et al. Gene Expression Profiling in Blood Provides Reproducible Molecular Insights into Asthma Control. American Journal of Respiratory and Critical Care Medicine 2017; 195(2): 179-188. doi: 10.1164/rccm.201601-0107OC.

5

Javor J, Chmurova N, Parnicka Z, Ferencik S, Grosse-Wilde H, Buc M, Svecova D. TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population. Journal of the European Academy of Dermatology and Venereology 2010; 24(1): 65-68. doi: 10.1111/j.1468-3083.2009.03260.x.

Cited in: Assaf S, Malki L, Mayer T, Mohamad J, Peled A, Pavlovsky M, Malovitski K, Sarig O, Vodo D, Sprecher E. ST18 affects cell-cell adhesion in pemphigus vulgaris in a tumour necrosis factor-α-dependent fashion. The British Journal of Dermatology 2021; 184(6): 1153-1160. doi: 10.1111/bjd.19679.

Cited in: Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. The Journal of Allergy and Clinical Immunology 2020; 145(4): 1031-1047. doi: 10.1016/j.jaci.2020.02.013.

Cited in: Gao J, Zhu C, Zhang Y, Sheng Y, Yang F, Wang W, Qian W, Chen S, Zhu Q, Zuo X, Tang H, Tang X, Li Y, Cheng H, Zhou F, Liu S, Chen G, Zheng X, Zhu Z, Wang Z, Yang S, Luo X, Ye D, Zhang X, Sun L. Association Study and Fine-Mapping Major Histocompatibility Complex Analysis of Pemphigus Vulgaris in a Han Chinese Population. The Journal of Investigative Dermatology 2018; 138(11): 2307-2314. doi: 10.1016/j.jid.2018.05.011.

Cited in: Sarig O, Bercovici S, Zoller L, Goldberg I, Indelman M, Nahum S, Israeli S, Sagiv N, Martinez de Morentin H, Katz O, Baum S, Barzilai A, Trau H, Murrell DF, Bergman R, Hertl M, Rosenberg S, Nöthen MM, Skorecki K, Schmidt E, Zillikens D, Darvasi A, Geiger D, Rosset S, Ibrahim SM, Sprecher E. Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. The Journal of Investigative Dermatology 2012; 132(7): 1798-1805. doi: 10.1038/jid.2012.46.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Co-investigator: Slovak Research and Development Agency

APVV-22-0231 - Therapeutic potential of stress-reducing intervention in complex cancer care

2023 - 2027

2

Co-investigator: Scientific Grant Agency of the Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences

VEGA 1/0426/24 - Molecular mechanisms of fibrotic and inflammatory processes of diffuse parenchymal lung diseases - analyzes of defined markers in bronchoalveolar lavages and their significance in clinical practice

2024 - 2027

3

Co-investigator: Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences

VEGA 1/0758/20 - Diffuse parenchymal lung diseases - inflammation, immunological mechanisms and determination of novel markers for diagnosis and differential diagnosis

2020 - 2022

4

Co-investigator: Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences

VEGA 1/0738/20 - Biomarkers of inflammation in patients with Alzheimer's disease

2020 - 2023

5

Co-investigator: Vedecká grantová agentúra Ministerstva školstva, vedy, výskumu a športu Slovenskej republiky a Slovenskej akadémie vied

VEGA 1/0212/17 - TREM-1, TREM-2 tests as new diagnostic and differential-diagnostic tests for sarcoidosis and other diffuse parenchymal lung diseases. Attempt at immunological classification of pulmonary diseases

2017 - 2019

6

Co-investigator: Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences

VEGA 1/0240/16 - Immunogenetic markers in Slovak patients with Alzheimer's disease

2016 - 2019

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Institute of Immunology, University Hospital of Essen Essen, Germany 2016 – three-month study stay (September – November) Short-Term Fellowship of European Federation of Immunological Societies (EFIS), under the leadership of prof. Dr. Hans Grosse-Wilde and dr. Stanislav Ferenčík
Department of Immunology, Faculty of Medicine and Dentistry, Palacký University Olomouc Olomouc, Czech Republic 2005, 2006, 2008, 2009 - 4x one-week study stay under the leadership of prof. Dr. Martin Petřek, CSc. and assoc. prof. Dr. František Mrázek, PhD.

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

2013 - prize of the Slovak Immunological Society at SAV for the best publication of 2012 (Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children)


Guest Editor of "Life" Journal (MDPI, Q2, IF = 3,2), Special Issue "Molecular Pathomechanisms and Biomarkers of Alzheimer's Disease" in 2023


Guest Editor of "Life" Journal (MDPI, Q2, IF = 3,2), Special Issue "Alzheimer's Disease: From Pathogenesis to Therapy" in 2023-2024

Date of last update
2025-01-16